In prostate cancer, FEN1 is overexpressed and is associated with a high Gleason score, which suggests that FEN1 might be a potential marker for prostate cancer diagnosis and therapy (Lam et al., 2006; Posadas et al., 2009). Here, FEN1 is linked to Familial prostate cancer.